Reconcile Chewable Tablets for Dogs 64mg (Fluoxetine) Pack of 30

Understanding Canine Separation Anxiety

Separation anxiety in dogs can manifest through various challenging behaviours, including destructive tendencies, excessive vocalisation (barking, howling), and inappropriate urination or defecation when left alone. Reconcile Chewable Tablets for Dogs 64mg (Fluoxetine) Pack of 30 are designed to help alleviate these symptoms, allowing your dog to feel calmer and more secure in your absence. It's crucial that this medication is used in conjunction with a comprehensive behaviour modification program recommended by your veterinary surgeon, as the tablets alone are not a cure.

How Reconcile Works

The active ingredient, Fluoxetine, is an SSRI that helps balance serotonin levels in your dog's brain. Serotonin is a neurotransmitter that plays a key role in regulating mood, anxiety, and behaviour. By gently increasing serotonin availability, Reconcile Chewable Tablets for Dogs 64mg (Fluoxetine) Pack of 30 can help reduce anxiety and improve your dog's ability to cope with being separated from you.

Obtaining Your Vet Prescription Medication

As a veterinary prescription-only medicine (Vet POM), Reconcile Chewable Tablets for Dogs 64mg (Fluoxetine) Pack of 30 requires a valid prescription from your vet before it can be dispensed. Weldricks Pharmacy makes it easy to fulfil your vet prescriptions online, offering a reliable and convenient service for your pet's healthcare needs. Simply upload your prescription, and we'll handle the rest, with discreet packaging and free UK delivery on orders over £40.

Supporting Your Dog's Journey

For more general advice on caring for your canine companion, explore our Animal Care Guide or learn about common issues like hayfever in pets. If you have questions about handling vet prescriptions, our guide on Understanding Vet Prescriptions might also be helpful.

Reconcile should be administered orally at a once daily dose of 1 to 2 mg/kg bodyweight according to the dosage table below:

Clinical improvement with Reconcile Chewable Tablets for Dogs 64mg (Fluoxetine) Pack of 30 is typically expected within 1 to 2 weeks. If no improvement is noted within 4 weeks, case management should be re-evaluated by your veterinary surgeon.

Reconcile tablets may be given with or without food. The tablets are flavoured and most dogs will readily consume them when offered by the owner.

If a dose is missed, the next scheduled dose should be administered as prescribed. At the end of treatment, it is not necessary to taper or reduce doses because of the long half-life of this veterinary medicinal product.

• Contraindications:
  • Do not use in dogs weighing less than 32 kg.
  • Do not use in dogs with epilepsy or in dogs with a history of seizures.
  • Do not use in case of hypersensitivity to fluoxetine or other Selective Serotonin Re-Uptake Inhibitors (SSRIs) or to any of the excipients.
• Special precautions for use in animals:
  • The safety of Reconcile Chewable Tablets for Dogs  has not been established in dogs less than 6 months of age or weighing less than 4 kg.
  • Though rare, seizures may occur in dogs treated with Reconcile. Treatment should be stopped immediately if seizures occur.
• Special precautions to be taken by the person administering the veterinary medicinal product to animals:
  • In case of accidental self-ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
  • In humans, the most common symptoms associated with overdose include seizures, somnolence, nausea, tachycardia, and vomiting.
• Adverse reactions (frequency and seriousness):

  To minimise the risk of adverse reactions, the recommended dose should not be exceeded. Reported adverse reactions include:

  • Very common (more than 1 in 10 animals treated): Decreased appetite (including anorexia), lethargy (including calmness and increased sleeping).
  • Common (more than 1 but less than 10 animals in 100 treated): Urinary tract disorders (such as bladder infections, irregular urination, discomfort in passing urine), central nervous system signs (incoordination, disorientation).
  • Uncommon (more than 1 but less than 10 animals in 1,000 treated): Weight loss/loss of condition, dilation of the pupils of the eye.
  • Rare (more than 1 but less than 10 animals in 10,000 treated): Panting, seizures, vomiting.

  If you notice any side effects not listed, please inform your veterinary surgeon.

• Use during pregnancy, lactation or lay:

  The safety of Reconcile Chewable Tablets for Dogs 64mg (Fluoxetine) Pack of 30 has not been established during pregnancy and lactation, thus its use is not recommended. Do not use in breeding animals.

• Interaction with other medicinal products and other forms of interaction:
  • Reconcile should not be given concomitantly with veterinary medicinal products that lower the seizure threshold (e.g. phenothiazines such as acepromazine or chlorpromazine).
  • Do not use the product in conjunction with other serotonergic agents (e.g. sertraline) and monoamine oxidase inhibitors (MAOIs) [e.g., selegiline hydrochloride (L-deprenyl), amitraz] or tricyclic amines (TCAs) (e.g. amitriptyline and clomipramine).
  • A 6-week washout interval should be observed following discontinuation of therapy with the product prior to the administration of any veterinary medicinal product that may adversely interact with fluoxetine or its metabolite, norfluoxetine.
• Overdose (symptoms, emergency procedures, antidotes):

  At doses exceeding the recommended dose, observed side effects at the therapeutic dose, including seizures, are exacerbated. Aggressive behaviour has also been observed.

• Special precautions for storage:
  • Do not store Reconcile Chewable Tablets for Dogs 64mg (Fluoxetine) Pack of 30 above 30 °C.
  • Store in the original container. Keep the bottle tightly closed in order to protect from moisture.
  • Do not remove the desiccant.
• Shelf life:
  • Shelf life of the veterinary medicinal product as packaged for sale: 2 years.
  • Shelf life after first opening the immediate packaging: 30 days. Discard any tablets remaining in the container after the shelf life has expired.
• Disposal:

  Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.

Each Reconcile Chewable Tablet 64mg contains:

• Active Substance: Fluoxetine 64 mg (equivalent to 72.34 mg fluoxetine hydrochloride)

Excipients:

• Microcrystalline cellulose
• Sucrose (as compressible sugar)
• Crospovidone
• Artificial beef flavour
• Silica, colloidal anhydrous
• Calcium hydrogen phosphate dihydrate
• Magnesium stearate